2015 Financial Press Releases

Keyword Search
 
2015 | 2014 | 2013 | 2012 | 2011
DateTitle 
04/09/15Accuray To Report Results For Third Quarter Fiscal 2015 On April 30, 2015
SUNNYVALE, Calif., April 9, 2015 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its third quarter ended March 31, 2015 on April 30, 2015 after the market close.  Management will host a conference call to review the results at 1:30 p.m. PT/4:30 p.m. ET on the same day. The conference call dial-in numbers are (855) 798-3048 (USA) or (262) 912-4764 (International).  In addition, a dial up replay of the conference call will be available approximately one hour after th... 
Printer Friendly Version
03/05/15Accuray and Christie InnoMed Sign Exclusive Sales Agent Agreements for Radiation Therapy Systems in Canada
SUNNYVALE, Calif., March 5, 2015 -- Accuray Incorporated (Nasdaq: ARAY) and Christie InnoMed Inc. announced today that they have entered into sales agent agreements involving the CyberKnife® and TomoTherapy® System product portfolios in Canada. Under the terms of these agreements, Christie InnoMed will be the exclusive sales agent for Accuray products in this region. "Christie InnoMed is a well-respected organization known for representing high-quality, leading-edge products. By joining force... 
Printer Friendly Version
03/02/15First Patient Treatment with the CyberKnife® M6™ System and the InCise™ Multileaf Collimator Has Been Completed
Patient with Brain Tumor Received Extremely Precise Treatment in Reduced Time SUNNYVALE, Calif., March 2, 2015 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that the first patient treatment has been completed using the CyberKnife® M6™ System with the InCise™ Multileaf Collimator (MLC). The treatment was administered as a multidisciplinary effort between Dr. Steven Burton from the Department of Radiation Oncology and Dr. Johnathan Engh from the Department of Neurosurgery ... 
Printer Friendly Version
02/24/15Lancaster General Health Receives First Commercial InCise™ Multileaf Collimator for the CyberKnife® M6™ System
SUNNYVALE, Calif. and LANCASTER, Pa., Feb. 24, 2015 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) and Lancaster General Health announced today that the first commercially available InCise™ Multileaf Collimator (MLC) for the CyberKnife® M6™ System has been received by Lancaster. The hospital selected the InCise MLC based on its ability to increase the system's treatment efficiency and extend its unique capabilities to a broader range of patient cases. Evaluation of the InCise MLC with t... 
Printer Friendly Version
02/17/15Class A User Licenses for Accuray Products Awarded to 16 Hospitals in China
SUNNYVALE, Calif., Feb. 17, 2015 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced that class A user licenses for Accuray products were awarded to 16 hospitals during February by the Chinese National Health and Family Planning Commission (NHFPC). TomoTherapy® System licenses were received by 12 hospitals and CyberKnife® System licenses were received by four hospitals. Of the 16 licenses just issued, Accuray believes that six licenses will allow orders already in backlog to be recogni... 
Printer Friendly Version
02/09/15Accuray to Participate in the Cowen 35th Annual Healthcare Conference
SUNNYVALE, Calif., Feb. 9, 2015 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today that its management is scheduled to present at the Cowen 35th Annual Healthcare Conference in Boston on Monday, March 2, 2015 at 2:10pm ET.  A live webcast of the presentation will be available on the Investor Relations page of the Company's website at http://www.accuray.com/investors.  The webcast replay of the presentation will begin approximately one hour after the conclusion of the live prese... 
Printer Friendly Version
02/04/15First TomoTherapy® System in Latin America Dedicated Solely to Breast Cancer Care Now Treating Patients
Advanced Radiation Therapy System Ideally Suited for Efficient, Effective Treatment of Range of Breast Cancer Cases SUNNYVALE, Calif., Feb. 4, 2015 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that the first TomoTherapy® System in Latin America dedicated solely to the treatment of breast cancer is now operational at FUCAM (Fundacion de Cancer de Mama) in Mexico City. More than 120 women have been treated with the innovative radiation therapy technology since the center ... 
Printer Friendly Version
01/27/15Accuray Reports Financial Results for Second Quarter of Fiscal Year 2015
SUNNYVALE, Calif., Jan. 27, 2015 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today financial results for the second fiscal quarter and six months ended December 31, 2014. Second Quarter Highlights Generates improved order volume with gross orders of $72.3 million Increases total revenue by 5% to $98.2 million from year ago period Expands service gross profit margins sequentially to 36% from 31% Achieves adjusted EBITDA of $3.7 million                             ... 
Printer Friendly Version
01/12/15Accuray To Report Results For Second Quarter Fiscal 2015 On January 27, 2015
SUNNYVALE, Calif., Jan. 12, 2015 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its second quarter ended December 31, 2014 on January 27, 2015 after the market close.  Management will host a conference call to review the results at 1:30 p.m. PT/4:30 p.m. ET on the same day. The conference call dial-in numbers are 888-539-3612 (USA) or 719-325-2494 (International).  In addition, a dial up replay of the conference call will be available approximately one hour after ... 
Printer Friendly Version